Skip to content

User login

Navigation

Follow us!

FDA Patient Safety News

Syndicate content PSN Logo
A Video News Show for Health Professionals. New broadcasts monthly, with online video and transcripts.
Updated: 5 min 2 sec ago

Recalls and Safety Alerts: Safety Precautions for Huber Needles

Mon, 03/01/2010 - 05:00
FDA is alerting healthcare professionals about safety precautions to be used with Huber needles, and about a recall of one company's products. Huber needles are used to access ports implanted in chronically ill patients to withdraw blood and infuse ...

Recalls and Safety Alerts: Don't Use Thermoflect Products with MRI

Mon, 03/01/2010 - 05:00
The manufacturer Encompass Group is alerting healthcare professionals that Thermoflect products should not be used in an MRI environment. These products, such as blankets and apparel, are intended to prevent hypothermia by keeping patients warm usin...

Recalls and Safety Alerts: Valproate Sodium and Birth Defects

Mon, 03/01/2010 - 05:00
FDA is reminding healthcare professionals and patients about an increased risk of birth defects in infants whose mothers took valproate sodium and related products during pregnancy. These drugs, which are used to treat epilepsy, bipolar disorder and...

Recalls and Safety Alerts: Kidney Impairment with Byetta

Mon, 03/01/2010 - 05:00
To help clinicians weigh the benefits and risks of the diabetes drug Byetta (exenatide), FDA is requiring that information about the risk of renal impairment be added to the drug's labeling. From April 2005 to October 2008, FDA received 78...

Recalls and Safety Alerts: Cleviprex Recalled due to Particulates

Mon, 03/01/2010 - 05:00
Here's information about a recall of certain lots of Cleviprex injectable emulsion, an antihypertensive drug made by The Medicines Company. Vials in the recalled lots may contain particulate matter which has been found to be inert stainless ste...

Preventing Medical Errors: Warning on Counterfeit Alli

Mon, 03/01/2010 - 05:00
FDA is warning the public about a potentially dangerous counterfeit version of the weight-loss drug Alli (orlistat). To date, all the counterfeits seem to have been sold on the internet. The genuine version of Alli, which is approved by FDA for ove...

Preventing Medical Errors: Medical Errors from Misreading Letters and Numbers

Mon, 03/01/2010 - 05:00
An article by the Institute for Safe Medication Practices (ISMP) reminds healthcare practitioners how dangerous it can be to misread the letters and numbers on prescriptions, drug orders and medical records. Unfortunately, these mistakes are easy to...

FDA Consumer Corner: Caution about Sexual Enhancement Products

Mon, 03/01/2010 - 05:00
You can easily find them on the internet - products sold as "dietary supplements" to enhance sexual performance or treat erectile dysfunction. Many of these products are said to be "all natural" alternatives to prescription drugs. That might make y...

FDA Consumer Corner: Ear Candles: Ineffective and Risky

Mon, 02/01/2010 - 05:00
FDA is warning people not to use ear candles because they can cause serious injury. An ear candle is a hollow cone about 10 inches long made from a fabric tube soaked in beeswax or paraffin. They are promoted and sold in health food stores, health ...

Recalls and Safety Alerts: Caution on Powerheart and CardioVive Automated External Defibrillators

Mon, 02/01/2010 - 05:00
FDA is alerting users of certain Powerheart and CardioVive automated external defibrillators that these devices may malfunction unexpectedly. This can cause a failure to deliver the electric shocks that are needed to treat sudden cardiac arrest or a...

Recalls and Safety Alerts: Cardiovascular Problems with Lexiva

Mon, 02/01/2010 - 05:00
GlaxoSmithKline is notifying healthcare professionals that Lexiva (fosamprenavir calcium), a protease inhibitor, has been associated with an increased risk of myocardial infarction and dyslipidemia in HIV infected adults. The company's letter recomm...

Recalls and Safety Alerts: FDA Recommendations on STERIS SYSTEM 1 Processor

Mon, 02/01/2010 - 05:00
Update 02/02/10: FDA is extending to 18 months the total recommended time period for transitioning from Steris Corporation?s modified System 1 processor (SS1) to legally-marketed alternative devices. See "Additional Information" link below. FDA ha...

Recalls and Safety Alerts: Chondrolysis with Continuously Infused Local Anesthetics

Mon, 02/01/2010 - 05:00
FDA is notifying healthcare professionals about chondrolysis in patients receiving continuous intra-articular infusion of local anesthetics to treat post-surgical pain. FDA has received a number of reports of cartilage necrosis and destruction in th...

Recalls and Safety Alerts: Synex II Spinal Implant Recalled

Mon, 02/01/2010 - 05:00
In September, the device company Synthes USA recalled the Synex II Vertebral Body Replacement device, a titanium implant used to replace an unstable or damaged vertebral body in the T1 to L5 portion of the spine. The devices were recalled after ...

Recalls and Safety Alerts: New Warnings on Norpramin

Mon, 02/01/2010 - 05:00
Sanofi-Aventis is notifying healthcare professionals about updated safety information for the antidepressant Norpramin (desipramine hydrochloride). The section on overdosage now notes that overdoses of this drug have resulted in a higher death rate ...

Recalls and Safety Alerts: Preventing Cross-Contamination in Endoscope Processing

Mon, 02/01/2010 - 05:00
The FDA, the CDC and the Department of Veterans Affairs have issued a joint safety communication cautioning healthcare facilities about the risks to patients if endoscopes and their accessories are not processed properly between patients. The commun...

Preventing Medical Errors: Mixups between Kapidex and Casodex

Mon, 02/01/2010 - 05:00
The Institute for Safe Medication Practices (ISMP) has reported medication errors due to name confusion between Kapidex (dexlansoprazole) and Casodex (bicalutamide). Kapidex is used to treat erosive esophagitis and gastroesophageal reflux disease. ...

Recalls and Safety Alerts: Emergency Use of Peramivir to Treat H1N1

Fri, 01/01/2010 - 05:00
FDA has authorized the emergency use of the investigational antiviral drug peramivir for certain adults and children hospitalized with confirmed or suspected 2009 H1N1 influenza. This includes patients who have an influenza A virus that is non-subty...

Recalls and Safety Alerts: Serious Complications with Negative Pressure Wound Therapy

Fri, 01/01/2010 - 05:00
FDA is alerting healthcare professionals and patients about deaths and serious complications from Negative Pressure Wound Therapy (NPWT). This therapy promotes wound healing by applying negative pressure to remove fluids and infectious materials from...

Recalls and Safety Alerts: Warning Against Nebulizing Relenza Inhalation Powder

Fri, 01/01/2010 - 05:00
GlaxoSmithKline is alerting healthcare professionals about the dangers of reconstituting Relenza (zanamivir) Inhalation Powder into a liquid and using it in a nebulizer or mechanical ventilator. The powder, which is used in the treatment and prophyl...
AdaptiveThemes